GB201400311D0 - Treating Susceptibility - Google Patents
Treating SusceptibilityInfo
- Publication number
- GB201400311D0 GB201400311D0 GBGB1400311.5A GB201400311A GB201400311D0 GB 201400311 D0 GB201400311 D0 GB 201400311D0 GB 201400311 A GB201400311 A GB 201400311A GB 201400311 D0 GB201400311 D0 GB 201400311D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treating susceptibility
- susceptibility
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1400311.5A GB201400311D0 (en) | 2014-01-08 | 2014-01-08 | Treating Susceptibility |
PCT/GB2015/050031 WO2015104551A1 (en) | 2014-01-08 | 2015-01-08 | Treating susceptibility |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1400311.5A GB201400311D0 (en) | 2014-01-08 | 2014-01-08 | Treating Susceptibility |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201400311D0 true GB201400311D0 (en) | 2014-02-26 |
Family
ID=50191069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1400311.5A Ceased GB201400311D0 (en) | 2014-01-08 | 2014-01-08 | Treating Susceptibility |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201400311D0 (en) |
WO (1) | WO2015104551A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201701480D0 (en) * | 2017-01-30 | 2017-03-15 | Aquagen As | Disease resistance |
GB202112807D0 (en) * | 2021-09-08 | 2021-10-20 | Univ Edinburgh | Genetic resistance to viral disease in salmonid fish |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2039168A1 (en) * | 1989-09-04 | 1991-03-05 | Yuto Kamei | Neutralizing monoclonal antibody to infectious pancreatic necrosis virus |
WO1994004565A2 (en) * | 1992-08-26 | 1994-03-03 | Proteus Molecular Design Limited | Ipnv vaccine |
WO2003013597A1 (en) * | 2001-08-10 | 2003-02-20 | University Of Maryland Biotechnology Institute | Sub-unit vaccine for infectious pancreatic necrosis virus |
GB2477712A (en) * | 2006-12-20 | 2011-08-17 | Advanced Bionutrition Corp | Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast |
WO2008097654A1 (en) * | 2007-02-08 | 2008-08-14 | Merck & Co., Inc. | Methods of using saha for treating hiv infection |
NO332608B2 (en) * | 2011-03-16 | 2012-11-19 | Fish Vet Group Fvg | Live avirulent IPNV and vaccine for prophylaxis or treatment of IPN disease in fish |
US9345760B2 (en) * | 2011-09-09 | 2016-05-24 | Advanced Bionutrition Corporation | IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same |
ES2711086T3 (en) * | 2011-10-03 | 2019-04-30 | Univ Bruxelles | Reactivation of HIV-1 gene expression to treat persistent HIV infection |
GB201212069D0 (en) * | 2012-07-06 | 2012-08-22 | Aqua Gen As | Predicting resistance to disease |
-
2014
- 2014-01-08 GB GBGB1400311.5A patent/GB201400311D0/en not_active Ceased
-
2015
- 2015-01-08 WO PCT/GB2015/050031 patent/WO2015104551A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015104551A1 (en) | 2015-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL248856B (en) | New treatment | |
GB201405800D0 (en) | Process | |
GB201404468D0 (en) | Process | |
GB201401430D0 (en) | Treatment process | |
GB201522243D0 (en) | Treatment | |
GB201502137D0 (en) | Treatment | |
GB201406890D0 (en) | Process | |
GB201405210D0 (en) | Process | |
GB201402950D0 (en) | Process | |
GB201409126D0 (en) | Process | |
GB201406989D0 (en) | Novel treatments | |
GB201402782D0 (en) | Process | |
PT3099317T (en) | Novel treatments | |
GB201412011D0 (en) | Treatments | |
GB201400137D0 (en) | Process | |
GB201508841D0 (en) | Treatment | |
GB201402909D0 (en) | Treating infection | |
GB201405209D0 (en) | Process | |
GB201400311D0 (en) | Treating Susceptibility | |
GB201411027D0 (en) | Treatment | |
GB201405929D0 (en) | Process | |
GB201403057D0 (en) | Process | |
GB201503008D0 (en) | Treatment | |
GB201518349D0 (en) | Treatment | |
GB201515739D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |